Literature DB >> 27812980

AMPK in Neurodegenerative Diseases.

Manon Domise1, Valérie Vingtdeux2.   

Abstract

Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis are neurodegenerative disorders that are characterized by a progressive degeneration of nerve cells eventually leading to dementia. While these diseases affect different neuronal populations and present distinct clinical features, they share in common several features and signaling pathways. In particular, energy metabolism defects, oxidative stress, and excitotoxicity are commonly described and might be correlated with AMP-activated protein kinase (AMPK) deregulation. AMPK is a master energy sensor which was reported to be overactivated in the brain of patients affected by these neurodegenerative disorders. While the exact role played by AMPK in these diseases remains to be clearly established, several studies reported the implication of AMPK in various signaling pathways that are involved in these diseases' progression. In this chapter, we review the current literature regarding the involvement of AMPK in the development of these diseases and discuss the common pathways involved.

Entities:  

Keywords:  AMPK; Alzheimer’s disease; Amyotrophic lateral sclerosis; Huntington’s disease; Neurodegeneration; Parkinson’s disease

Mesh:

Substances:

Year:  2016        PMID: 27812980     DOI: 10.1007/978-3-319-43589-3_7

Source DB:  PubMed          Journal:  Exp Suppl        ISSN: 1664-431X


  17 in total

1.  Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer's Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway.

Authors:  Lin Wang; Bing-Jin Liu; Yun Cao; Wei-Qi Xu; Dong-Sheng Sun; Meng-Zhu Li; Fang-Xiao Shi; Man Li; Qing Tian; Jian-Zhi Wang; Xin-Wen Zhou
Journal:  Mol Neurobiol       Date:  2017-07-17       Impact factor: 5.590

Review 2.  Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.

Authors:  Barry Boland; Wai Haung Yu; Olga Corti; Bertrand Mollereau; Alexandre Henriques; Erwan Bezard; Greg M Pastores; David C Rubinsztein; Ralph A Nixon; Michael R Duchen; Giovanna R Mallucci; Guido Kroemer; Beth Levine; Eeva-Liisa Eskelinen; Fanny Mochel; Michael Spedding; Caroline Louis; Olivier R Martin; Mark J Millan
Journal:  Nat Rev Drug Discov       Date:  2018-08-17       Impact factor: 84.694

3.  Deficiency of Parkinson's Related Protein DJ-1 Alters Cdk5 Signalling and Induces Neuronal Death by Aberrant Cell Cycle Re-entry.

Authors:  María José López-Grueso; Carmen Alicia Padilla; José Antonio Bárcena; Raquel Requejo-Aguilar
Journal:  Cell Mol Neurobiol       Date:  2022-02-19       Impact factor: 5.046

4.  AMPK Modulates the Metabolic Adaptation of C6 Glioma Cells in Glucose-Deprived Conditions without Affecting Glutamate Transport.

Authors:  Inês Belo do Nascimento; Marie Verfaillie; Gamze Ates; Pauline Beckers; Virginie Joris; Nathalie Desmet; Ann Massie; Emmanuel Hermans
Journal:  Cells       Date:  2022-05-31       Impact factor: 7.666

5.  NOX2-derived hydrogen peroxide impedes the AMPK/Akt-mTOR signaling pathway contributing to cell death in neuronal cells.

Authors:  Ruijie Zhang; Chunxiao Liu; Liu Yang; Tong Ji; Nana Zhang; Xiaoqing Dong; Xin Chen; Jing Ma; Wei Gao; Shile Huang; Long Chen
Journal:  Cell Signal       Date:  2022-04-04       Impact factor: 4.850

6.  AMPK activation by Tanshinone IIA protects neuronal cells from oxygen-glucose deprivation.

Authors:  Yingfeng Weng; Jixian Lin; Hui Liu; Hui Wu; Zhimin Yan; Jing Zhao
Journal:  Oncotarget       Date:  2017-12-17

7.  Salvianolic Acid B Improves Chronic Mild Stress-Induced Depressive Behaviors in Rats: Involvement of AMPK/SIRT1 Signaling Pathway.

Authors:  Dehua Liao; Yun Chen; Yujin Guo; Changshui Wang; Ni Liu; Qian Gong; Yingzhou Fu; Yilan Fu; Lizhi Cao; Dunwu Yao; Pei Jiang
Journal:  J Inflamm Res       Date:  2020-05-12

8.  Activity of translation regulator eukaryotic elongation factor-2 kinase is increased in Parkinson disease brain and its inhibition reduces alpha synuclein toxicity.

Authors:  Asad Jan; Brandon Jansonius; Alberto Delaidelli; Forum Bhanshali; Yi Andy An; Nelson Ferreira; Lisa M Smits; Gian Luca Negri; Jens C Schwamborn; Poul H Jensen; Ian R Mackenzie; Stefan Taubert; Poul H Sorensen
Journal:  Acta Neuropathol Commun       Date:  2018-07-02       Impact factor: 7.801

Review 9.  Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson's Disease.

Authors:  Daniel W Curry; Bernardo Stutz; Zane B Andrews; John D Elsworth
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

10.  AMP-Activated Protein Kinase Is Essential for the Maintenance of Energy Levels during Synaptic Activation.

Authors:  Claudia Marinangeli; Sébastien Didier; Tariq Ahmed; Raphaelle Caillerez; Manon Domise; Charlotte Laloux; Séverine Bégard; Sébastien Carrier; Morvane Colin; Philippe Marchetti; Bart Ghesquière; Detlef Balschun; Luc Buée; Jérôme Kluza; Valérie Vingtdeux
Journal:  iScience       Date:  2018-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.